Newstral
Article
Fft.com on 2019-07-22 16:00
Bayer to sell Dr Scholl’s to private equity in bid to focus on core
Related news
- Bayer to sell assets to BASF, 300 in N.C. impactedbizjournals.com
- Bayer to sell seed assets to ease antitrust concerns: Reportbizjournals.com
- FBayer to sell animal health business to Elanco for $7.6bnft.com
- Bayer to sell testosterone drug for up to €500mtimesofmalta.com
- Bayer to sell $9B in agriculture assets to buy Monsantobizjournals.com
- Bayer to sell assets to BASF, 300 in RTP impactedbizjournals.com
- PBayer to sell Liberty crop protection brands in Monsanto dealproducer.com
- Bayer agrees to sell its Dr. Scholl's businessbizjournals.com
- PBayer to sell Liberty crop protection brands to get Monsanto deal passedproducer.com
- Aegion to sell energy services segment to focus on core marketsbizjournals.com
- Monsanto deal prompts Bayer to sell pieces of unit with big KC presencebizjournals.com
- Bayer CEO plans to sell animal health operations by year endbizjournals.com
- Bayer wins anti-trust approval to sell a division for $7.6B, a sale driven by Roundupbizjournals.com
- Covestro to sell off part of former Bayer campus in Robinsonpost-gazette.com
- Covestro confirms deal in place to sell a major portion of former Bayer campus in Robinson to DiCicco Developmentbizjournals.com
- Ross to Sell Equity Investmentswsj.com
- MVista Outdoor to sell some eyewear brands for $158 million to focus on core ammunition, hydration brandsmarketwatch.com
- Core Energy to sell producing assetsjournalrecord.com
- Grocer Haggen to sell state's core storesKOMO News
- Kroger to sell brand to private equitybizjournals.com